The Beat Q2 2022

APRIL

Pam Wiltz | Director of Sales, Alternate Site Alt Sites Update

Wow, time flies when you are busy and focused on growth! It is hard to believe that we are almost at the end of Q1 2022.

Life appears to be getting back to normal. Our customers are ready to meet face to face as conference season kicks officially off. The National Home Infusion Association (NHIA) was held in Nashville from March 13 th – 16 th . Andrew Flessor, Dan Dulman, and I all attended. We had twenty-two (22) strategic meetings with customers, potential customers, manufacturers and one GPO partner scheduled over two and a half days. Phew! Exhausting, but quite productive for BioCare! It was interesting to see how well we all re-adjusted to the hectic conference schedule. It was like riding a bike, you never forget. The meetings were quite productive, and we are hopeful about several solid opportunities we are pursuing. Our focus on expanding the specialty business is a major part of the 2022 BioCareSD strategy. VYVGART launched in January. We have had good success in working with small to mid-size customers, connecting them with the manufacturer, and facilitating access to the product. The result has been an immediate increase in sales, but more importantly, we have become an invaluable partner to a customer that is rapidly growing. Our expertise, relationships and focus on the patient have been big components of this success. YTD VYVGART sales are $826,422. There are still several customers we are assisting through the approval process with the manufacturer. We expect to see VYVGART sales exponentially increase as the

medical community is better educated on the product and more patients are identified. Beyond VYVGART, we have had additional successes on expanding both ENTYVIO and TEPEZZA sales. YTD new business for these products are $1,560,422.00, with most of that total being purchased in March. In short, 2022 is off to great start! We are laser focused on new opportunities and are looking forward to another record year!

3

Powered by